Medication info
Decartan Tablet 8 mg (Candesartan Cilexetil)

Decartan Tablet 8 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Samik Pharmaceutical Co., Ltd.
Appearance
A light pink tablet that is convex on both sides.
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201904229 · Approved 2019.06.18 · Insurance code 644004220

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time every day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is reached within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with careful monitoring in patients at increased risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Ingredients

Manufacturer
Samik Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular contraction
  • reduced left ventricular ejection fraction
View approved original text

This medication helps to control essential hypertension and stabilize blood pressure. It is additionally used to improve heart function in heart failure patients with decreased left ventricular contraction, particularly when ACE inhibitor treatment is insufficient or poorly tolerated. As a result, it alleviates heart failure symptoms and contributes to enhancing the quality of life of patients. Therefore, this medication is used for the treatment of hypertension and certain heart failure patients.

How to take

Adult dose

This medicine should be taken at the same time every day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is reached within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with careful monitoring in patients at increased risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, immediate discontinuation is required upon confirmation of pregnancy. Women who are allergic to this medication or its ingredients, pregnant or nursing, patients with severe liver impairment, and those with certain genetic conditions should not take this medication. Particular caution should be exercised when using this medication in elderly patients, patients with hyperkalemia, patients with compromised liver or kidney function, patients with heart valve diseases, and regular monitoring of their condition according to a doctor's guidance is necessary. While taking this medication, side effects such as dizziness, back pain, and respiratory infections may occur, and in severe cases, treatment may need to be discontinued. In heart failure patients, side effects like hypotension, hyperkalemia, and worsening kidney function may occur more frequently, so it is important to regularly monitor potassium levels and kidney function through blood tests. Since this medication lowers blood pressure, patients at risk of excessively low blood pressure or those taking certain medications need to exercise additional caution. Interactions may occur if taken with other antihypertensives, diuretics, potassium supplements, etc., so consultation with a doctor or pharmacist is mandatory before use. There may be symptoms of dizziness or drowsiness when driving or operating machinery, thus caution is advised. The safety and efficacy of this medication in children and adolescents have not been established, so its use is not recommended. In the event of an overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, and immediate medical attention is required for appropriate treatment. Lastly, this medication should be kept out of reach of children, and transferring it to another container may compromise its quality, so caution is advised.

Side effects

  • Dizziness
  • lumbar pain
  • respiratory infection
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • fatigue
  • peripheral edema
  • chest pain
  • headache
Show 74 more
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • joint pain
  • proteinuria
  • asthenia
  • fever
  • sensory disturbance
  • dyspepsia
  • gastritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyperkalemia
  • hyponatremia
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • seizures
  • consciousness disturbance
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • renal impairment
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • syncope
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • decreased libido
  • forgetfulness
  • decreased appetite
  • increased appetite
  • tinnitus
  • taste disturbances
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly closed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the medication's efficacy.

Appearance and packaging

Appearance

A light pink tablet that is convex on both sides.

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.